A Lexington man was arrested after an alleged late‑night break‑in at Liberty Ordnance Supply in Norwood; police recovered several of the stolen guns and charges followed.

A motorcyclist died Sunday after a crash on VFW Parkway in West Roxbury; state troopers say speed during a passing maneuver may have been a factor.

State transportation officials say the MBTA will temporarily occupy a stretch of Summer Street for World Cup match days. The move has drawn pushback from Mayor Wu’s office ahead of June matches.

A Brockton man pleaded guilty to laundering more than $1.2 million in stolen tax refunds; prosecutors say he routed altered Treasury checks through a shell company. Sentencing is set for Aug. 6, 2026.

Haverhill PD has begun a phased rollout of department‑issued body cameras; officials say footage will aid investigations while privacy protections apply.

A four-alarm fire ripped through several triple-decker homes on Princeton Street Sunday; crews reported flames on rear porches and fought the blaze into the night. Investigators remained on scene.

State and federal teams are testing for PFAS at New Boston Space Force Station; one on‑base community well was treated and lawmakers want clarity on cleanup timelines.

Two people with gunshot wounds drove themselves to a hospital after early-morning gunfire near Talbot Avenue in Dorchester; detectives are investigating.

Cambridge police say a Somerville man was arrested in North Cambridge after a struggle that turned up a loaded .45, suspected fentanyl and fraudulent IDs.

One person was wounded Friday on Dorchester Avenue after gunfire erupted; witnesses say the victim walked to the Avenue Grill and police expect them to recover.

After 15 years, Scholars closes May 15–16, 2026 as Off The Rails prepares a late-summer relaunch at 25 School St with live music and Nashville-style food.

Healey announced final rules to curb insurer prior‑authorization delays at Dana‑Farber, with patient advocate Chuck Stravin among speakers.

CREATE Medicines, cofounded by Siddhartha Mukherjee, closed a $122M Series B to advance in‑vivo CAR‑T candidates for cancer and autoimmune disease.